New Research Can Help in Treating Tuberculosis Effectively
One-third of people in the world suffer from Tuberculosis. 2 million individuals lose their lives owing to this dreadful lung disease. It is caused by the bacterium Mycobacterium tuberculosis. The infection spread by this pathogen destroys the tissues of the organ. When the patient coughs, this pathogen is transmitted to other individuals through air.
A challenge before the medical fraternity is the fact that this bacterium is increasingly becoming drug-resistant. The mechanism of the disease was poorly understood until now. As a result, its prevention was not possible.
Researchers from the Imperial College London, Columbia University in New York and the University of East Anglia have found that the levels of an enzyme MMP-1 is high in the lungs of the TB patients. Drugs to inhibit the raise of this enzyme exist already.
This new development has increased the hopes of treating the disease quickly in near future. The results of the study are published in the April 2011 edition of the Journal of Clinical Investigation.